A new survey suggests many people with ALS would value even modest slowing of ALS progression as a treatment goal.

Ochsner Neuroscience Institute is marking the 10-year anniversary of its Amyotrophic Lateral Sclerosis (ALS) Center, a recognized Center of ...

The ALS Center was established in November 2015 with a clear mission to offer comprehensive, patient-centered care for individuals with ALS and to support their families. This commitment to holistic ...

The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the SOD1 gene.

ARLINGTON, Va., Feb. 3, 2026 /PRNewswire/ -- The ALS Association today applauded the reintroduction of the ALS Better Care Act bipartisan legislation to expand access to high-quality multidisciplinary ...

KNOXVILLE, Tenn. — A nonprofit dedicated to helping people with ALS is donating money to a specialty clinic in Knoxville. The ALS Clinic at the University of Tennessee Medical Center is a one-stop ...

PathMaker Neurosystems Inc. ('PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...

More than two hours into a sold-out concert at Austin’s Paramount Theatre last week, a tall, graceful woman strolled onto ...

The global food allergy market is estimated at USD 44.1 billion in 2025 and is projected to reach USD 73.2 billion by 2035, expanding at a 5.2% CAGR over the forecast period, according to the latest ...

Prolonged exposure to air pollution can be linked to an elevated risk for serious neurodegenerative diseases like ALS and seems to speed up the pathological process, report researchers from Karolinska ...

There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug, with ...